FDA Approved: PERPHENAZINE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Wilshire Pharmaceuticals’ supplemental application for PERPHENAZINE. The approval updates the generic's regulatory status under the ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• PERPHENAZINE (Perphenazine)

Snippet

SUPPL AP for PERPHENAZINE (PERPHENAZINE)